Drugs to improve anaemia, quality of life, and physical function in people with myelodysplastic syndromes (MDS).

Mo A., Poynton M., Kimber C., Csenar M., Dorée C., Prodger C., Stanworth S., McQuilten Z.

This is a protocol for a Cochrane Review (intervention). The objectives are as follows: To evaluate the benefits and harms of both supportive and disease-modifying drug treatments for anaemia in people with MDS, comparing them to each other, or the standard of care with or without placebo.

DOI

10.1002/14651858.CD016362

Type

Journal article

Publication Date

2026-07-03T00:00:00+00:00

Volume

7

Keywords

Humans, Myelodysplastic Syndromes, Anemia, Quality of Life, Randomized Controlled Trials as Topic, Hematinics, Physical Functional Performance, Erythropoietin

Permalink More information Close